PMID: 33575961
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.
Khavinson V Kh, Kuznik B I, Trofimova S V, Volchkov V A, Rukavishnikova S A, Titova O N, Akhmedov T A, Trofimov A V, Potemkin V V, Magen E
Stem cell reviews and reports · 2021
Vol. 17, Issue 1, pp. 285-290
This entry links to third-party literature. For research use only.
COVID-19Cell DifferentiationCytokinesHematopoiesisHematopoietic Stem CellsHumansSARS-CoV-2Thymus GlandThymus HormonesCOVID-19 Drug Treatment